Cargando…
IL-20 bone diseases involvement and therapeutic target potential
BACKGROUND: Millions of people around the world suffer from bone disorders, likes osteoporosis, rheumatoid arthritis (RA), and cancer-induced osteolysis. In general, the bone remodeling balance is determined by osteoclasts and osteoblasts, respectively responsible for bone resorption and bone format...
Autores principales: | Wang, Hsiao-Hsuan, Hsu, Yu-Hsiang, Chang, Ming-Shi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5913811/ https://www.ncbi.nlm.nih.gov/pubmed/29690863 http://dx.doi.org/10.1186/s12929-018-0439-z |
Ejemplares similares
-
Interleukin-20 is involved in dry eye disease and is a potential therapeutic target
por: Wang, Hsiao-Hsuan, et al.
Publicado: (2022) -
IL-20 in Acute Kidney Injury: Role in Pathogenesis and Potential as a Therapeutic Target
por: Lin, Tian-Yu, et al.
Publicado: (2020) -
Anti-IL-20 monoclonal antibody promotes bone fracture healing through regulating IL-20-mediated osteoblastogenesis
por: Hsu, Yu-Hsiang, et al.
Publicado: (2016) -
Anti–IL-20 monoclonal antibody inhibits the differentiation of osteoclasts and protects against osteoporotic bone loss
por: Hsu, Yu-Hsiang, et al.
Publicado: (2011) -
Anti-IL-20 Monoclonal Antibody Suppresses Prostate Cancer Growth and Bone Osteolysis in Murine Models
por: Hsu, Yu-Hsiang, et al.
Publicado: (2015)